Daniel L. Levin

5.8k total citations · 2 hit papers
107 papers, 3.8k citations indexed

About

Daniel L. Levin is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, Daniel L. Levin has authored 107 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 28 papers in Surgery and 24 papers in Epidemiology. Recurrent topics in Daniel L. Levin's work include Neonatal Respiratory Health Research (17 papers), Respiratory Support and Mechanisms (12 papers) and Congenital Heart Disease Studies (12 papers). Daniel L. Levin is often cited by papers focused on Neonatal Respiratory Health Research (17 papers), Respiratory Support and Mechanisms (12 papers) and Congenital Heart Disease Studies (12 papers). Daniel L. Levin collaborates with scholars based in United States, United Kingdom and Canada. Daniel L. Levin's co-authors include Michaël Heymann, Abraham M. Rudolph, Ronald M. Perkin, Roderic H. Phibbs, Lawrence J. Mills, Chim C. Lang, James A. Royall, Arthur G. Weinberg, Joseph A. Kitterman and George A. Gregory and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Daniel L. Levin

103 papers receiving 3.5k citations

Hit Papers

Anti-Inflammatory Effects of Metformin Irrespective of Di... 2015 2026 2018 2022 2016 2015 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel L. Levin United States 33 1.5k 1.1k 803 663 530 107 3.8k
Andreas Huber Switzerland 40 1.0k 0.7× 866 0.8× 923 1.1× 739 1.1× 414 0.8× 187 5.2k
Giliola Calori Italy 44 934 0.6× 1.4k 1.3× 1.2k 1.4× 794 1.2× 1.6k 2.9× 114 6.3k
Massimo Círillo Italy 36 760 0.5× 837 0.8× 871 1.1× 540 0.8× 1.1k 2.1× 195 5.1k
Marie Westwood United Kingdom 32 804 0.5× 742 0.7× 587 0.7× 418 0.6× 361 0.7× 57 4.2k
Brian Shine United Kingdom 33 556 0.4× 927 0.9× 785 1.0× 1.2k 1.9× 423 0.8× 127 3.8k
Timothy S. Larson United States 47 1.4k 1.0× 2.3k 2.1× 658 0.8× 416 0.6× 540 1.0× 105 7.7k
Vedat Schwenger Germany 37 787 0.5× 1.3k 1.2× 448 0.6× 355 0.5× 660 1.2× 197 4.6k
Tun‐Jun Tsai Taiwan 41 758 0.5× 928 0.9× 588 0.7× 400 0.6× 480 0.9× 177 5.3k
Thomas L. Nickolas United States 47 546 0.4× 1.3k 1.2× 683 0.9× 399 0.6× 287 0.5× 107 6.5k
Adrian Spitzer United States 27 1.2k 0.8× 642 0.6× 527 0.7× 257 0.4× 363 0.7× 101 5.5k

Countries citing papers authored by Daniel L. Levin

Since Specialization
Citations

This map shows the geographic impact of Daniel L. Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Levin more than expected).

Fields of papers citing papers by Daniel L. Levin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel L. Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Levin. The network helps show where Daniel L. Levin may publish in the future.

Co-authorship network of co-authors of Daniel L. Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel L. Levin. A scholar is included among the top collaborators of Daniel L. Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel L. Levin. Daniel L. Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levin, Daniel L., et al.. (2025). Engineering an electroactive bacterial cellulose-carbon nanotube composite membrane against Staphylococcus aureus. Biofilm. 10. 100305–100305. 1 indexed citations
2.
Levin, Daniel L., Holly Lee, Jason Tay, et al.. (2023). Daratumumab for the treatment of relapsed/refractory AL amyloidosis: experience from the amyloidosis Program of Calgary (APC). Leukemia & lymphoma. 65(3). 403–406.
4.
Moonah, Shannon, Daniel L. Levin, Eugene D. McGahren, et al.. (2020). Acute appendicitis in four children with SARS-CoV-2 infection. SHILAP Revista de lepidopterología. 64. 101734–101734. 33 indexed citations
6.
Mordi, Ify, J. Graeme Houston, Helen M. Colhoun, et al.. (2018). Epicardial adipose tissue is related to arterial stiffness and inflammation in patients with cardiovascular disease and type 2 diabetes. BMC Cardiovascular Disorders. 18(1). 31–31. 36 indexed citations
7.
Levin, Daniel L., Louise Marryat, Tim Cole, et al.. (2016). Fit to WHO weight standard of European infants over time. Archives of Disease in Childhood. 101(5). 455–460. 6 indexed citations
8.
Elder, Douglas H.J., Jagdeep Singh, Daniel L. Levin, et al.. (2015). Mean HbA1c and Mortality in Diabetic Individuals with Heart Failure: A Population Cohort Study. European Journal of Heart Failure. 18(1). 94–102. 69 indexed citations
9.
Lang, Chim C., Daniel L. Levin, Mohapradeep Mohan, et al.. (2015). EFFECT OF GLYCAEMIC CONTROL ON OUTCOME IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC HEART FAILURE. Journal of the American College of Cardiology. 65(10). A886–A886. 2 indexed citations
10.
Bell, Samira, Helen C. Looker, Daniel L. Levin, et al.. (2014). End-stage renal disease and survival in people with diabetes: a national database linkage study. QJM. 108(2). 127–134. 54 indexed citations
11.
Levin, Daniel L.. (2008). Cerebral edema in diabetic ketoacidosis. Pediatric Critical Care Medicine. 9(3). 320–329. 56 indexed citations
12.
Rosenstock, C., et al.. (2005). Inter‐observer agreement of tests used for prediction of difficult laryngoscopy/tracheal intubation. Acta Anaesthesiologica Scandinavica. 49(8). 1057–1062. 30 indexed citations
13.
Thomas, James A., et al.. (1997). Successful treatment of severe dysrhythmias in infants with respiratory syncytial virus infections. Critical Care Medicine. 25(5). 880–886. 26 indexed citations
14.
Slusher, Tina M., Daniel Gbadero, Cynthia R. Howard, et al.. (1996). Randomized, placebo-controlled, double blinded trial of dexamethasone in African children with sepsis. The Pediatric Infectious Disease Journal. 15(7). 579–583. 35 indexed citations
15.
Dark, Diana S., M. O. Farber, Kathryn Rice, et al.. (1995). Oral ofloxacin versus cefaclor for LRTIs in adults. 12(10). 551–556. 1 indexed citations
16.
Lindsay, Christine A., Gary Williams, & Daniel L. Levin. (1995). Fatal adult respiratory distress syndrome after diphenhydramine toxicity in a child. Critical Care Medicine. 23(4). 777–781. 9 indexed citations
17.
Levin, Daniel L., et al.. (1993). Brain death in the pediatric patient. Critical Care Medicine. 21(Supplement). S337–S338. 3 indexed citations
18.
Royall, James A. & Daniel L. Levin. (1988). Adult respiratory distress syndrome in pediatric patients. I. Clinical aspects, pathophysiology, pathology, and mechanisms of lung injury. The Journal of Pediatrics. 112(2). 169–180. 69 indexed citations
19.
Perkin, Ronald M. & Daniel L. Levin. (1982). Shock in the pediatric patient. Part I. The Journal of Pediatrics. 101(2). 163–169. 43 indexed citations
20.
Perkin, Ronald M., et al.. (1980). Serum salicylate levels and right-to-left ductus shunts in newborn infants with persistent pulmonary hypertension. The Journal of Pediatrics. 96(4). 721–726. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026